Page 9 - சிகிச்சை எதிர்ப்பு மனச்சோர்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing Co-lead investors RA Capital and RTW Investments, LP invest alongside existing investor BVF Partners and other new investors in Series B financing Use of proceeds to support further clinical development of GH001 (5-MeO-DMT) in Treatment-Resistant Depression (TRD) and to advance GH001 into further clinical development in additional psychiatric and neurological disorders News provided by Share this article Share this article DUBLIN, April 12, 2021 /PRNewswire/ GH Research Ireland Ltd ( GH Research , the Company or We ) today announced the closing of a $125 million Series B financing co-led by RA Capital and RTW Investments, LP, U.S.-based biopharmaceutical investment firms, alongside existing investor BVF Partners. Other new investors in the Series B round included Acuta Capital Partners, Boxer Capital, Cormorant Asset Management, Deerfield Management Company, Logos Capital, Surveyor Capital (a C

Deerfield management companyGh research ireland ltdPrnewswire gh research ireland ltdGh researchSource gh research ltdGh research forward lookingVerition fund managementCompany or weIreland ltdAcuta capital partnersBoxer capitalCormorant asset managementLogos capitalSurveyor capitalVenrock healthcare capital partnersVerition fund